nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts from the Society for Clinical Trials Annual Meeting, Miami, May 21–23, 2012
|
|
|
2012 |
9 |
4 |
p. 450-554 |
artikel |
2 |
A method for utilizing co-primary efficacy outcome measures to screen regimens for activity in two-stage Phase II clinical trials
|
Sill, Michael W |
|
2012 |
9 |
4 |
p. 385-395 |
artikel |
3 |
An adaptive design to bridge the gap between Phase 2b/3 microbicide effectiveness trials and evidence required for licensure
|
Taylor, Douglas J |
|
2012 |
9 |
4 |
p. 377-384 |
artikel |
4 |
An eClinical trial system for cancer that integrates with clinical pathways and electronic medical records
|
Yamamoto, Keiichi |
|
2012 |
9 |
4 |
p. 408-417 |
artikel |
5 |
A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials
|
Carpenter, William R |
|
2012 |
9 |
4 |
p. 426-435 |
artikel |
6 |
Author contact information
|
|
|
2012 |
9 |
4 |
p. 555-556 |
artikel |
7 |
Clinician-trialist rounds: 11. When your grant gets turned down – part 1: remorse, anger, and reconciliation
|
Szatmari, Peter |
|
2012 |
9 |
4 |
p. 447-449 |
artikel |
8 |
Evolution of the study coordinator role: The 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
|
Larkin, Mary E |
|
2012 |
9 |
4 |
p. 418-425 |
artikel |
9 |
Including all individuals is not enough: Lessons for intention-to-treat analysis
|
White, Ian R |
|
2012 |
9 |
4 |
p. 396-407 |
artikel |
10 |
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research
|
Chalkidou, Kalipso |
|
2012 |
9 |
4 |
p. 436-446 |
artikel |